Other clinical and histopathological characteristics such as volume, tumor location, lymph-vascular invasion, and diffusion-weighted imaging radiomics may also be good signatures for distinguishing positive and negative status of hormone receptors in breast cancer (25, 34). This evidence concerns the gene NR4A1 and breast carcinoma.